Sign Up
Stories
ABVC BioPharma's Patent and Partnership
Share
Advancements in Psychiatric Treatments
Cognition Supplements Market Forecasts
Growing Psychosis Therapy Market
Arizona Psilocybin Research Grant
Arizona's Psilocybin Research Grant Open...
FDA Finds No Preliminary Link Between Oz...
Overview
API
ABVC BioPharma secures Australian patent for MDD treatment, ABV-1504, and enters licensing agreement with AiBtl BioPharma Inc. The company's assets have potential in the MDD and ADHD markets.
Ask a question
How do the growth potential of the MDD and ADHD markets influence the strategic direction of ABVC BioPharma?
How might the patent for PDC-1421 impact the competitive landscape in the MDD market?
What are the potential implications of ABVC BioPharma's collaboration with AiBtl BioPharma Inc. for the development of new treatments?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage